Dr. Shital Sarah Ahaley

Dr. Shital Sarah Ahaley

B.Sc. Microbiology, M.Sc. Microbiology, Ph.D. Developmental Biology

Dr. Shital Sarah Ahaley is a medical writer. She completed her Bachelor's and Master's degree in Microbiology at the University of Pune. She then completed her Ph.D. at the Indian Institute of Science, Bengaluru where she studied muscle development and muscle diseases. After her Ph.D., she worked at the Indian Institute of Science, Education, and Research, Pune as a post-doctoral fellow. She then acquired and executed an independent grant from the DBT-Wellcome Trust India Alliance as an Early Career Fellow. Her work focused on RNA binding proteins and Hedgehog signaling.

See more

She has excellent communication skills and knowledge of scientific publishing with experience in writing scientific documents and grants. She has presented her work in several national and international conferences. With more than 12 years of experience in academia, she has developed strong scientific expertise and teaching skills.

She has always been a curious individual. This led her to pursue a Ph.D. in developmental biology. Apart from the pursuit of knowledge, she takes pleasure in communicating it to a wide range of audiences. She is also a prolific writer. This led her to the path of a medical writer. In this role, she enjoys employing her passion for writing along with her scientific expertise to communicate science.

Besides medical writing, she relishes writing poems, short stories, and plays.

See less

Articles from Shital

No evidence of SARS-CoV-2 in the U.K.'s wild deer population

No evidence of SARS-CoV-2 in the U.K.'s wild deer population

The longest duration of SARS-CoV-2 positivity after initial diagnosis

The longest duration of SARS-CoV-2 positivity after initial diagnosis

Immunity against SARS-CoV-2 BA.1, BA.2, and BA.3 after three doses of BNT162b2 vaccine

Immunity against SARS-CoV-2 BA.1, BA.2, and BA.3 after three doses of BNT162b2 vaccine

Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

Adaptive immunity against SARS-CoV-2 is persistent and robust in COVID-convalescent children

Adaptive immunity against SARS-CoV-2 is persistent and robust in COVID-convalescent children

Predicting the risk of some common diseases in preimplantation fertilized embryos

Predicting the risk of some common diseases in preimplantation fertilized embryos

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

A circRNA COVID vaccine with potential to neutralize SARS-CoV-2 variants

A circRNA COVID vaccine with potential to neutralize SARS-CoV-2 variants

Study investigates population immunity to SARS-CoV-2 through heterogenous pathways

Study investigates population immunity to SARS-CoV-2 through heterogenous pathways

Study compares the neutralizing potential of antibodies against two Omicron variants

Study compares the neutralizing potential of antibodies against two Omicron variants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.